10.17037/DATA.00000766
Anonymised dataset supporting the Lancet Global Health paper, “Comparative efficacy of low-dose versus standard-dose azithromycin for patients with yaws: a randomised non-inferiority trial in Ghana and Papua New Guinea".
The dataset contains 15 variables.
Variable name | Variable description | Answer code | Answer label | Variable type |
country | Country name | String | ||
Ghana | Ghana | |||
PNG | Papua New Guinea | |||
age | Participant age | Open ended | Numeric | |
sex | Participant sex | String | ||
Female | Female | |||
Male | Male | |||
0 | Not recorded | |||
lesiontype | Lesion type | String | ||
Papillomata | Papillomata | |||
Ulcer | Ulcer | |||
0 | Not recorded | |||
arm | Trial arm to which participant was assigned | String | ||
30mg | Treatment with 30 mg/kg | |||
20mg | Treatment with 20 mg/kg | |||
Not Randomised | Not Randomised | |||
TPPCR | Treponema pallidum Polymerase Chain Reaction (TP-PCR) | Numeric | ||
0 | Negative | |||
1 | Positive | |||
HDPCR | Haemophilus ducreyi Polymerase Chain Reaction (HD-PCR) | Numeric | ||
0 | Negative | |||
1 | Positive | |||
lesion4 | Status of skin lesion healing at 4 weeks | String | ||
Completely healed | Completely healed | |||
Partially healed | Partially healed | |||
No improvement | No improvement | |||
Data at 4wks missing | Missing data at 4 weeks | |||
Lost | Lost to followup | |||
0 | Not recorded | |||
rprquan0 | Rapid Plasma Reagin (RPR) test - titre 0 | Numeric | ||
rprquan6 | Rapid Plasma Reagin (RPR) test - titre 6 | Numeric | ||
reason_not_rand | Reason participant was not randomised | String | ||
Randomised | Participant was randomised | |||
T1 neg | T1 negative | |||
T2 neg | T2 negative | |||
T1&T2 neg | T1 and T2 negative | |||
T1 or T2 missing | T1 or T2 missing | |||
Unwell at sceening | Unwell at screening | |||
Unable to take blood | Unable to take blood | |||
Unknown reason | Unknown reason | |||
hd_tp | Treponema pallidum (TP) and Haemophilus ducreyi (HD) result | String | ||
TP- HD- | TP Negative, HP negative | |||
TP- HD+ | TP Negative, HP positive | |||
TP+ HD- | TP positive, HP negative | |||
TP+ HD+ | TP positive, HP positive | |||
0 | Not recorded | |||
excluded | Reason for participant exclusion | String | ||
4 Week Lesion Data Mission | 4 week Lesion data mission | |||
Included in Primary Analysis | Included in Primary Analysis | |||
Missing 6 Month Follow-up RPR | Missing 6 Month Follow-up RPR | |||
Missing Baseline PCR | Missing Baseline PCR | |||
Missing Basline RPR | Missing Baseline RPR | |||
Negative RPR at baseline | Negative RPR at baseline | |||
Patient did not meet trial inclusion criteria | Patient did not meet trial inclusion criteria | |||
lesion_location | Lesion location on body | String | ||
Arm | Arm | |||
Back | Back | |||
Face/Neck | Face/Neck | |||
Leg | Leg | |||
Missing | Missing | |||
Trunk | Trunk | |||
overalloutcome | Overall outcome | String | ||
Clinical Cure & Serological Cure | Clinical cure AND Serological Cure | |||
Clinical Cure & Non-Significant RPR Change | Clinical cure AND non-significant RPR change | |||
Clinical Failure & Non-Significant RPR Change | Clinical failure AND non-significant RPR change | |||
Clinical Failure BUT Serological Cure | Clinical failure BUT serological cure | |||
Clinical Cure BUT Serological Failure | Clinical cure BUT Serological failure | |||
Exlcuded from Primary Analysis | Excluded from primary analysis |